KEYTRUDA COST - AN OVERVIEW

Overview Pembrolizumab (Keytruda): CADTH Reimbursement Suggestion: Sign: Together with chemotherapy, for your procedure of adult people with regionally recurrent unresectable or metastatic triple-unfavorable breast most cancers who have not acquired prior chemotherapy for metastatic ailment and whose tumours Convey programmed cell Demise-ligand 1 (